1. Exploring the stereochemical requirements for protease inhibition by ureidopeptides
- Author
-
Mark A. Lipton, Myers Ac, and Barth Bs
- Subjects
chemistry.chemical_classification ,Protease ,Kunitz STI protease inhibitor ,Protein Conformation ,Stereochemistry ,medicine.medical_treatment ,Peptide ,HIV Protease Inhibitors ,Tripeptide ,Substrate analog ,Biochemistry ,chemistry.chemical_compound ,Endocrinology ,Enzyme ,chemistry ,Amide ,medicine ,Urea ,Peptide bond ,Peptides - Abstract
A novel 'ureidopeptide' substrate analog inhibitor of the HIV-1 protease, created by substitution of a urea for the scissile amide bond of a hexapeptide substrate, was synthesized and tested for inhibition of HIV-1 protease. This inhibitor was designed as a stereochemical mutant of an earlier ureidopeptide inhibitor in which the P1' phenylalanine residue was changed from an l-isomer to a d-isomer. This was done in an attempt to increase binding to the enzyme by compensating for a lengthening of the peptide backbone. The inhibitor was synthesized from two protected tripeptide precursors using an oxidative Hoffmann rearrangement of a C-terminal peptide amide. The new inhibitor was found to inhibit HIV-1 protease with an observed IC(50) of 47 mum.
- Published
- 2005
- Full Text
- View/download PDF